The first CRISPR Medicine Conference 2024
Apr. 23, 2024
The 2nd CRISPR Medicine Conference 2025
- Jun. 26, 2024
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Type 1 Primary Hyperoxaluria, PH1, (NCT06892301)
Sponsors:
Guangzhou Women and Children's Medical Center
Sponsors:
Guangzhou Women and Children's Medical Center
IND Enabling
Phase I
Phase II
Phase III
End-Stage Renal Disease, (NCT07053462)
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
IND Enabling
Phase I
Phase II
Phase III
